Cetera Advisor Networks’s Microbot Medical MBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-10,800
Closed -$15K 2837
2023
Q3
$15K Buy
+10,800
New +$23.4K ﹤0.01% 2677
2023
Q2
Sell
-10,101
Closed -$21K 2671
2023
Q1
$21K Sell
10,101
-900
-8% -$2.66K ﹤0.01% 2529
2022
Q4
$33.1K Sell
11,001
-1,648
-13% -$6.84K ﹤0.01% 2464
2022
Q3
$60K Buy
12,649
+101
+0.8% +$519 ﹤0.01% 2005
2022
Q2
$64K Buy
12,548
+100
+0.8% +$556 ﹤0.01% 1990
2022
Q1
$78K Buy
+12,448
New +$72.9K ﹤0.01% 1993

Other funds holding MBOT

Cetera Advisor Networks's MBOT Position: Q4 2023 in Review

Cetera Advisor Networks sold out of Microbot Medical (MBOT) in Q4 2023, closing a stake of 10,800 shares — an estimated $15K sold.

Cetera Advisor Networks first reported a position in MBOT in Q1 2022 and held it in 6 quarters. The position peaked at $78K in Q1 2022. 36 funds tracked by Wall St. Rank hold MBOT as of Q4 2023.

  • Cetera Advisor Networks reported no remaining Microbot Medical position as of Q4 2023 after selling out during the quarter.
  • Cetera Advisor Networks sold 10,800 Microbot Medical shares in Q4 2023, an estimated $15K.
  • Cetera Advisor Networks first reported a position in Microbot Medical in Q1 2022 and held it in 6 quarters.
  • Cetera Advisor Networks's Microbot Medical position peaked at $78K in Q1 2022.
  • 36 funds tracked by Wall St. Rank held Microbot Medical as of Q4 2023.

Based on Cetera Advisor Networks's 13F filing for Q4 2023, filed 13 Feb 2024.